VIVE logo

Viveve Medical (VIVE) Cash From Financing

Annual CFF

$25.97 M
+$16.74 M+181.40%

December 31, 2021

Summary

Performance

1-Year Change

+181.4%

3-Year Change

-51.92%

5-Year Change

-48.97%

15-Year Change

-48.97%

VIVE Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

70.47%
VIVE annual cash flow from financing activities is higher than 70.47% of companies in Healthcare sector

High & Low

All-time High

$54.02 M
VIVE annual cash flow from financing activities is currently -51.92% below its historical high of $54.02 million

3-Year Low

$25.97 M
VIVE annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
VIVE previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
VIVE next annual earnings announcement has not yet been scheduled

OtherVIVEcash flowmetrics:

Annual CFI

-$456.00 K
VIVE annual cash flow from investing activities is -$456.00 thousand

Annual CFO

-$12.88 M
VIVE annual cash flow from operations is -$12.88 million

Annual FCF

-$13.33 M
VIVE annual free cash flow is -$13.33 million

Annual CAPEX

$456.00 K
VIVE annual capital expenditures is $456.00 thousand

Quarterly CFF

$19.00 K
+$6000.00+46.15%

September 30, 2022

Summary

Performance

3-Month Change

+46.15%

1-Year Change

-9.52%

3-Year Change

-99.7%

5-Year Change

+100%

VIVE Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.25%
VIVE quarterly cash flow from financing activities is higher than 48.25% of companies in Healthcare sector

High & Low

All-time High

$33.30 M
VIVE quarterly cash flow from financing activities is currently -99.94% below its historical high of $33.30 million

3-Year Low

$13.00 K
VIVE quarterly cash flow from financing activities is currently +46.15% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVE previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVE next earnings announcement has not yet been scheduled

OtherVIVEcash flowmetrics:

Quarterly CFI

-$193.00 K
VIVE quarterly cash flow from investing activities is -$193.00 thousand

Quarterly CFO

-$3.35 M
VIVE quarterly cash flow from operations is -$3.35 million

Quarterly FCF

-$3.54 M
VIVE quarterly free cash flow is -$3.54 million

Quarterly CAPEX

$193.00 K
VIVE quarterly capital expenditures is $193.00 thousand

TTM CFF

$69.00 K
-$2000.00-2.82%

September 30, 2022

Summary

Performance

3-Month Change

-2.82%

1-Year Change

-99.73%

3-Year Change

-99.57%

5-Year Change

-99.57%

VIVE TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

27.67%
VIVE TTM cash flow from financing activities is higher than 27.67% of companies in Healthcare sector

High & Low

All-time High

$54.02 M
VIVE TTM cash flow from financing activities is currently -99.87% below its historical high of $54.02 million

3-Year Low

$69.00 K
VIVE TTM cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
VIVE previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
VIVE next earnings announcement has not yet been scheduled

OtherVIVEcash flowmetrics:

TTM CFI

-$595.00 K
VIVE TTM cash flow from investing activities is -$595.00 thousand

TTM CFO

-$16.23 M
VIVE TTM cash flow from operations is -$16.23 million

TTM FCF

-$16.83 M
VIVE TTM free cash flow is -$16.83 million

TTM CAPEX

$595.00 K
VIVE TTM capital expenditures is $595.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

VIVE Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+181.4%-9.5%-99.7%
3 y3 years-51.9%-99.7%-99.6%
5 y5 years-49.0%+100.0%-99.6%

VIVE Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+46.1%-99.7%at low
5 y5-yearat high+181.4%-99.9%+2000.0%-99.8%at low
alltimeall time-51.9%>+9999.0%-99.9%+107.1%-99.9%+170.4%

Viveve Medical Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2022
-
$19.00 K(+46.2%)
$69.00 K(-2.8%)
Jun 2022
-
$13.00 K(-31.6%)
$71.00 K(-90.3%)
Mar 2022
-
$19.00 K(+5.6%)
$731.00 K(-97.2%)
Dec 2021
$25.97 M(+181.4%)
$18.00 K(-14.3%)
$25.97 M(+0.1%)
Sep 2021
-
$21.00 K(-96.9%)
$25.95 M(-12.0%)
Jun 2021
-
$673.00 K(-97.3%)
$29.49 M(-10.3%)
Mar 2021
-
$25.26 M(<-9900.0%)
$32.86 M(+256.0%)
Dec 2020
$9.23 M(-42.7%)
-$1000.00(-100.0%)
$9.23 M(-51.6%)
Sep 2020
-
$3.56 M(-12.0%)
$19.07 M(-12.6%)
Jun 2020
-
$4.04 M(+147.8%)
$21.83 M(+23.3%)
Mar 2020
-
$1.63 M(-83.4%)
$17.70 M(+9.9%)
Dec 2019
$16.11 M(-70.2%)
$9.84 M(+55.7%)
$16.11 M(-39.7%)
Sep 2019
-
$6.32 M(-7997.5%)
$26.70 M(+30.5%)
Jun 2019
-
-$80.00 K(-328.6%)
$20.46 M(-1.4%)
Mar 2019
-
$35.00 K(-99.8%)
$20.76 M(-61.6%)
Dec 2018
$54.02 M(+6.1%)
$20.43 M(>+9900.0%)
$54.02 M(+23.4%)
Sep 2018
-
$75.00 K(-65.8%)
$43.79 M(+0.2%)
Jun 2018
-
$219.00 K(-99.3%)
$43.72 M(-17.0%)
Mar 2018
-
$33.30 M(+226.6%)
$52.70 M(+3.5%)
Dec 2017
$50.90 M(+166.9%)
$10.20 M(>+9900.0%)
$50.90 M(+25.1%)
Sep 2017
-
$0.00(-100.0%)
$40.70 M(-0.1%)
Jun 2017
-
$9.20 M(-70.8%)
$40.77 M(-19.8%)
Mar 2017
-
$31.50 M(>+9900.0%)
$50.84 M(+166.6%)
Dec 2016
$19.07 M(+1.6%)
$0.00(-100.0%)
$19.07 M(-21.5%)
Sep 2016
-
$60.00 K(-99.7%)
$24.30 M(-3.7%)
Jun 2016
-
$19.28 M(-7266.5%)
$25.24 M(+44.2%)
Mar 2016
-
-$269.00 K(-105.1%)
$17.50 M(-6.8%)
Dec 2015
$18.77 M(+185.5%)
$5.23 M(+421.0%)
$18.77 M(+30.2%)
Sep 2015
-
$1.00 M(-91.3%)
$14.41 M(-22.6%)
Jun 2015
-
$11.54 M(+1054.0%)
$18.61 M(+145.8%)
Mar 2015
-
$1.00 M(+15.1%)
$7.57 M(+15.2%)
Dec 2014
$6.57 M(+23.3%)
$869.00 K(-83.3%)
$6.57 M(+15.2%)
Sep 2014
-
$5.20 M(+940.8%)
$5.70 M(+174.9%)
Jun 2014
-
$500.00 K(>+9900.0%)
$2.08 M(+31.7%)
Mar 2014
-
$0.00(0.0%)
$1.57 M(-70.4%)
Dec 2013
$5.33 M(+479.2%)
$0.00(-100.0%)
$5.33 M(0.0%)
Sep 2013
-
$1.57 M(>+9900.0%)
$5.33 M(+14.0%)
Jun 2013
-
$0.00(-100.0%)
$4.67 M(0.0%)
Mar 2013
-
$3.75 M(>+9900.0%)
$4.67 M(+408.0%)
Dec 2012
$920.00 K(-74.5%)
$0.00(-100.0%)
$920.00 K(0.0%)
Sep 2012
-
$920.00 K(>+9900.0%)
$920.00 K(>+9900.0%)
Jun 2012
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2011
$3.60 M(>+9900.0%)
$0.00(0.0%)
$3.60 M(0.0%)
Sep 2011
-
$0.00(0.0%)
$3.60 M(0.0%)
Jun 2011
-
$0.00(-100.0%)
$3.60 M(0.0%)
Mar 2011
-
$3.60 M(>+9900.0%)
$3.60 M(>+9900.0%)
Dec 2010
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2010
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2010
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2010
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2009
-
$0.00(-100.0%)
$1000.00(-50.0%)
Dec 2008
$2000.00(-77.8%)
$1000.00(>+9900.0%)
$2000.00(-33.3%)
Sep 2008
-
$0.00(-100.0%)
$3000.00(-66.7%)
Jun 2008
-
$1000.00(>+9900.0%)
$9000.00(0.0%)
Mar 2008
-
$0.00(-100.0%)
$9000.00(0.0%)
Dec 2007
$9000.00
$2000.00(-66.7%)
$9000.00(-79.5%)
Sep 2007
-
$6000.00(+500.0%)
$44.00 K(+15.8%)
Jun 2007
-
$1000.00(>+9900.0%)
$38.00 K(-73.2%)
DateAnnualQuarterlyTTM
Mar 2007
-
$0.00(-100.0%)
$142.00 K(-2.1%)
Dec 2006
$145.00 K(+2316.7%)
$37.00 K(>+9900.0%)
$145.00 K(+34.3%)
Sep 2006
-
$0.00(-100.0%)
$108.00 K(0.0%)
Jun 2006
-
$105.00 K(+3400.0%)
$108.00 K(+1100.0%)
Mar 2006
-
$3000.00(>+9900.0%)
$9000.00(+50.0%)
Dec 2005
$6000.00(-93.7%)
$0.00(0.0%)
$6000.00(-45.5%)
Sep 2005
-
$0.00(-100.0%)
$11.00 K(0.0%)
Jun 2005
-
$6000.00(>+9900.0%)
$11.00 K(+22.2%)
Mar 2005
-
$0.00(-100.0%)
$9000.00(-90.5%)
Dec 2004
$95.00 K(-209.2%)
$5000.00(>+9900.0%)
$95.00 K(+69.6%)
Sep 2004
-
$0.00(-100.0%)
$56.00 K(+33.3%)
Jun 2004
-
$4000.00(-95.3%)
$42.00 K(+82.6%)
Mar 2004
-
$86.00 K(-352.9%)
$23.00 K(-126.4%)
Dec 2003
-$87.00 K(-289.1%)
-$34.00 K(+142.9%)
-$87.00 K(-3000.0%)
Sep 2003
-
-$14.00 K(-6.7%)
$3000.00(-114.3%)
Jun 2003
-
-$15.00 K(-37.5%)
-$21.00 K(-131.3%)
Mar 2003
-
-$24.00 K(-142.9%)
$67.00 K(+45.7%)
Dec 2002
$46.00 K(-98.8%)
$56.00 K(-247.4%)
$46.00 K(-235.3%)
Sep 2002
-
-$38.00 K(-152.1%)
-$34.00 K(-17.1%)
Jun 2002
-
$73.00 K(-262.2%)
-$41.00 K(-58.2%)
Mar 2002
-
-$45.00 K(+87.5%)
-$98.00 K(-102.6%)
Dec 2001
$3.77 M(-25.4%)
-$24.00 K(-46.7%)
$3.77 M(+3.9%)
Sep 2001
-
-$45.00 K(-381.3%)
$3.63 M(-6.9%)
Jun 2001
-
$16.00 K(-99.6%)
$3.89 M(+1.5%)
Mar 2001
-
$3.82 M(-2414.5%)
$3.84 M(-24.0%)
Dec 2000
$5.05 M(+26.8%)
-$165.00 K(-174.0%)
$5.05 M(-2.8%)
Sep 2000
-
$223.00 K(-657.5%)
$5.19 M(-27.6%)
Jun 2000
-
-$40.00 K(-100.8%)
$7.17 M(-8.2%)
Mar 2000
-
$5.03 M(<-9900.0%)
$7.81 M(+96.2%)
Dec 1999
$3.98 M(-26.3%)
-$21.00 K(-101.0%)
$3.98 M(-5.3%)
Sep 1999
-
$2.20 M(+266.7%)
$4.20 M(+82.6%)
Jun 1999
-
$600.00 K(-50.0%)
$2.30 M(-64.1%)
Mar 1999
-
$1.20 M(+500.0%)
$6.40 M(+18.5%)
Dec 1998
$5.40 M(-74.0%)
$200.00 K(-33.3%)
$5.40 M(-16.9%)
Sep 1998
-
$300.00 K(-93.6%)
$6.50 M(-74.1%)
Jun 1998
-
$4.70 M(+2250.0%)
$25.10 M(+22.4%)
Mar 1998
-
$200.00 K(-84.6%)
$20.50 M(-1.4%)
Dec 1997
$20.80 M(+700.0%)
$1.30 M(-93.1%)
$20.80 M(+6.7%)
Sep 1997
-
$18.90 M(>+9900.0%)
$19.50 M(+2337.5%)
Jun 1997
-
$100.00 K(-80.0%)
$800.00 K(0.0%)
Mar 1997
-
$500.00 K(>+9900.0%)
$800.00 K(-69.2%)
Dec 1996
$2.60 M(+420.0%)
$0.00(-100.0%)
$2.60 M(0.0%)
Sep 1996
-
$200.00 K(+100.0%)
$2.60 M(+8.3%)
Jun 1996
-
$100.00 K(-95.7%)
$2.40 M(+4.3%)
Mar 1996
-
$2.30 M(+1050.0%)
$2.30 M(-74.4%)
Dec 1995
$500.00 K(-94.4%)
-
-
Dec 1994
$9.00 M(+91.5%)
$200.00 K(-97.7%)
$9.00 M(+1.1%)
Sep 1994
-
$8.60 M(>+9900.0%)
$8.90 M(+1383.3%)
Jun 1994
-
$0.00(-100.0%)
$600.00 K(-86.0%)
Mar 1994
-
$200.00 K(+100.0%)
$4.30 M(-8.5%)
Dec 1993
$4.70 M(-7.8%)
$100.00 K(-66.7%)
$4.70 M(-9.6%)
Sep 1993
-
$300.00 K(-91.9%)
$5.20 M(-42.9%)
Jun 1993
-
$3.70 M(+516.7%)
$9.10 M(+68.5%)
Mar 1993
-
$600.00 K(0.0%)
$5.40 M(+5.9%)
Dec 1992
$5.10 M(-32.9%)
$600.00 K(-85.7%)
$5.10 M(+13.3%)
Sep 1992
-
$4.20 M(>+9900.0%)
$4.50 M(+1400.0%)
Jun 1992
-
$0.00(-100.0%)
$300.00 K(0.0%)
Mar 1992
-
$300.00 K
$300.00 K
Dec 1991
$7.60 M(>+9900.0%)
-
-
Dec 1990
$0.00
-
-

FAQ

  • What is Viveve Medical annual cash flow from financing activities?
  • What is the all time high annual CFF for Viveve Medical?
  • What is Viveve Medical annual CFF year-on-year change?
  • What is Viveve Medical quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Viveve Medical?
  • What is Viveve Medical quarterly CFF year-on-year change?
  • What is Viveve Medical TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Viveve Medical?
  • What is Viveve Medical TTM CFF year-on-year change?

What is Viveve Medical annual cash flow from financing activities?

The current annual CFF of VIVE is $25.97 M

What is the all time high annual CFF for Viveve Medical?

Viveve Medical all-time high annual cash flow from financing activities is $54.02 M

What is Viveve Medical annual CFF year-on-year change?

Over the past year, VIVE annual cash flow from financing activities has changed by +$16.74 M (+181.40%)

What is Viveve Medical quarterly cash flow from financing activities?

The current quarterly CFF of VIVE is $19.00 K

What is the all time high quarterly CFF for Viveve Medical?

Viveve Medical all-time high quarterly cash flow from financing activities is $33.30 M

What is Viveve Medical quarterly CFF year-on-year change?

Over the past year, VIVE quarterly cash flow from financing activities has changed by -$2000.00 (-9.52%)

What is Viveve Medical TTM cash flow from financing activities?

The current TTM CFF of VIVE is $69.00 K

What is the all time high TTM CFF for Viveve Medical?

Viveve Medical all-time high TTM cash flow from financing activities is $54.02 M

What is Viveve Medical TTM CFF year-on-year change?

Over the past year, VIVE TTM cash flow from financing activities has changed by -$25.89 M (-99.73%)